SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

PAQ Therapeutics to Present First Clinical Data for PT0253

The late-breaking oral presentation will highlight PT0253’s initial safety profile and antitumor activity in advanced so…

Related stories